Olema Pharmaceuticals, Inc.
Recent Filings
All 525 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G | — | Mar 20, 2026 |
| 144 | — | Mar 16, 2026 |
| 144 | — | Mar 16, 2026 |
| S-8 | S-8 | Mar 16, 2026 |
| 10-K | 10-K | Mar 16, 2026 |
| 8-K | 8-K | Mar 16, 2026 |
| 144 | — | Mar 11, 2026 |
| 144 | — | Mar 10, 2026 |
| 144 | — | Mar 9, 2026 |
| SCHEDULE 13G/A | — | Mar 6, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Harmon Cyrus | — | Sale | 2,881 @ $28.53 | 741,259 | Dec 22, 2025 |
| CLARK IAN T | — | Sale | 41,840 @ $30.48 | — | Dec 19, 2025 |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sale | 1,225 @ $28.08 | 601,656 | Dec 19, 2025 |
| Harmon Cyrus | — | Sale | 1,914 @ $8.08 | 120,114 | Sep 16, 2025 |
| Graham G. Walmsley | — | Sale | 700,761 @ $6.75 | — | Dec 17, 2024 |
| Graham G. Walmsley | — | Purchase | 700,761 @ $6.75 | 700,761 | Dec 13, 2024 |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Award / Grant | 48,750 | 624,399 | Dec 11, 2024 |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | Sale | 406 @ $9.39 | 543,549 | Dec 11, 2024 |
| Harmon Cyrus | — | Sale | 179 @ $9.39 | 764,140 | Dec 9, 2024 |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | Sale | 13,283 @ $9.37 | 130,031 | Dec 9, 2024 |